Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 536 Records) |
| Query Trace: Lung Neoplasms and TP53[original query] |
|---|
| Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas. Human pathology 2023 9 . Haiyue Wang, Linghua Yan, Yanli Zhu, Wei Sun, Xin Yang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Lixin Zhou, Dongmei L |
| Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance. Japanese journal of clinical oncology 2023 9 . Jie Zheng, Yuanyao Dou, Daijuan Huang, Yubo Wang, Rui Han, Chen Hu, Mengxiao Zhu, Conghua Lu, Caiyu Lin, Di Wu, Yihui Liu, Huan Tang, Tingting He, Weilin Jiang, Yong |
| The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non-small cell lung cancer. Cancer medicine 2023 9 . Takayuki Honda, Katsutoshi Seto, Satoshi Endo, Akira Takemoto, Kousuke Tanimoto, Masashi Kobayashi, Masatake Kitano, Rie Sakakibara, Takahiro Mitsumura, Hironori Ishibashi, Johji Inazawa, Toshihiro Tanaka, Yasunari Miyazaki, Kenichi Oku |
| Impact of ramucirumab plus erlotinib on circulating cell-free DNA from patients with untreated metastatic non-small cell lung cancer with EGFR-activating mutations (RELAY phase 3 randomized study). Translational lung cancer research 2023 9 12 (8): 1702-1716. Kazuto Nishio, Kazuko Sakai, Makoto Nishio, Takashi Seto, Carla Visseren-Grul, Michelle Carlsen, Tomoko Matsui, Sotaro Enatsu, Kazuhiko Nakaga |
| Clinico-genomic features and targetable mutations in non-small cell lung cancers harboring BRAF non-V600E mutations: A multi-institutional genomic screening study (LC-SCRUM-Asia). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 8 . Tetsuya Sakai, Shingo Matsumoto, Yasuto Ueda, Yuji Shibata, Takaya Ikeda, Atsushi Nakamura, Masahiro Kodani, Kadoaki Ohashi, Naoki Furuya, Hiroki Izumi, Kaname Nosaki, Shigeki Umemura, Yoshitaka Zenke, Hibiki Udagawa, Eri Sugiyama, Kiyotaka Yoh, Koichi Go |
| Race-Associated Genomic Correlates of Therapeutic Response in African American Patients With Non-Small-Cell Lung Cancer. JCO precision oncology 2023 8 7 e2300155. Pin Li, Kaitlyn Kane, Frank M Wolf, Anna B Berry, Shirish Gadgeel, Amanda Pilli |
| TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk. BMC cancer 2023 8 23 (1): 783. Daniel J Craig, Erin L Crawford, Heidi Chen, Eric L Grogan, Steven A Deppen, Thomas Morrison, Sanja L Antic, Pierre P Massion, James C Will |
| Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications. Lung cancer (Amsterdam, Netherlands) 2023 8 184 107317. Huriye Seker-Cin, Timothy Kwang Yong Tay, Daniel Kazdal, Klaus Kluck, Markus Ball, Olaf Neumann, Hauke Winter, Felix Herth, Claus-Peter Heußel, Rajkumar Savai, Peter Schirmacher, Michael Thomas, Jan Budczies, Michael Allgäuer, Petros Christopoulos, Albrecht Stenzinger, Anna-Lena Volckm |
| Impact of concurrent genomic alterations on clinical outcomes in patients with ALK-rearranged non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 8 . Luis Lara-Mejía, Andrés F Cardona, Luis Mas, Claudio Martín, Suraj Samtani, Luis Corrales, Graciela Cruz-Rico, Jordi Remon, Marco Galvez-Nino, Rossana Ruiz, Eduardo Rios-Garcia, Fernanda Tejada, Natalia Lozano-Vazquez, Rafael Rosell, Oscar Arrie |
| TP53 Exon 5 Mutation Indicates Poor Progression-Free Survival for Patients with Stage IV NSCLC. Frontiers in bioscience (Landmark edition) 2023 8 28 (7): 147. Huijing Feng, Huiru Xu, Xiuhuan Shi, Guobin Ding, Cihui Yan, Linhan Li, Zuoyi Jian, Xuejing Yang, Hongxia Guo, Feng Li, Junping Zhang, Xiubao R |
| Influence of PD-L1 expression on the efficacy of EGFR-TKIs in EGFR-mutant non-small cell lung cancer. Thoracic cancer 2023 7 . Si-Yu Lei, Hai-Yan Xu, Hong-Shuai Li, Ya-Ning Yang, Fei Xu, Jun-Ling Li, Zhi-Jie Wang, Pu-Yuan Xing, Xue-Zhi Hao, Yan Wa |
| Clinical Impact of Genomic and Pathway Alterations in Stage I EGFR-Mutant Lung Adenocarcinoma. Cancer research and treatment 2023 7 . Jae Seok Lee, Eun Kyung Kim, Kyung A Kim, Hyo Sup Sh |
| Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer. Human genomics 2023 7 17 (1): 66. Ning-Yuan Lee, Melissa Hum, Sabna Zihara, Lanying Wang, Matthew K Myint, Darren Wan-Teck Lim, Chee-Keong Toh, Anders Skanderup, Jens Samol, Min-Han Tan, Peter Ang, Soo-Chin Lee, Eng-Huat Tan, Gillianne G Y Lai, Daniel S W Tan, Yoon-Sim Yap, Ann S G L |
| Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2023 7 . Xiaohong Xie, Guihuan Qiu, Ziyao Chen, Ting Liu, Yilin Yang, Zhixuan You, Chen Zeng, Xinqing Lin, Zhanhong Xie, Yinyin Qin, Yansheng Wang, Xiaodong Ma, Chengzhi Zhou, Ming L |
| The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia. F1000Research 2023 7 11 853. Noni Novisari Soeroso, Fannie Rizki Ananda, Johan Samuel Sitanggang, Noverita Sprinse Vinoli |
| Clinical validity of oncogenic driver genes detected from circulating tumor DNA in the blood of lung cancer patients. Translational lung cancer research 2023 7 12 (6): 1185-1196. Sheehyun Kim, Sungjae Kim, Se Hyun Kim, Eun Hee Jung, Koung Jin Suh, Yu Jung Kim, Nak-Jung Kwon, Hyojin Kim, Jin-Haeng Chung, Jong Seok L |
| Molecular correlation of response to pyrotinib in advanced NSCLC with HER2 mutation: biomarker analysis from two phase II trials. Experimental hematology & oncology 2023 6 12 (1): 53. Shiqi Mao, Shuo Yang, Xinyu Liu, Xingya Li, Qiming Wang, Yiping Zhang, Jianhua Chen, Yan Wang, Guanghui Gao, Fengying Wu, Tao Jiang, Jiao Zhang, Ying Yang, Xiang Lin, Xiaoyu Zhu, Caicun Zhou, Shengxiang R |
| Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer. Medicine 2023 6 102 (26): e34143. Yin JiaXin, Cong XiaoFeng, Cui PengFei, Zhao Songchen, Liu Zili |
| Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results. ESMO open 2023 6 8 (4): 101580. E B Garon, M Reck, K Nishio, J V Heymach, M Nishio, S Novello, L Paz-Ares, S Popat, S Ponce Aix, H Graham, B D Butts, C Visseren-Grul, K Nakagawa, |
| Evaluation of the Analytical Performance of Oncomine Lung cfDNA Assay for Detection of Plasma EGFR Mutations. Genes 2023 6 14 (6): . Yong Gon Cho, Joonhong Park, Ji Yoon Han, Tae Yun K |
| Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC. Thoracic cancer 2023 6 . Xiya Ma, Kun Zhang, Jing Xu, Hongjun Gao, Shaoxing Yang, Haifeng Qin, Hong Wang, Fang Gao, Xiaoqing L |
| Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutations. BMC pulmonary medicine 2023 5 23 (1): 158. Jinfei Si, Yue Hao, Jingwen Wei, Jing Xiang, Chunwei Xu, Qiuping Shen, Zhengbo So |
| Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients. Pathology oncology research : POR 2023 5 29 1610951. Adi Horesh, Rena Pollack, Hovav Nechushtan, Rivka Dresner-Pollak, Tzahi Neum |
| Differences of genomic alterations and heavy metals in non-small cell lung cancer with different histological subtypes. Journal of cancer research and clinical oncology 2023 5 . Die Mu, Hui Tang, Gen Teng, Xinyang Li, Yarui Zhang, Ge Gao, Dongjuan Wang, Lu Bai, Xiangyao Lian, Ming Wen, Lisha Jiang, Shouxin Wu, Huihui Jiang, Cuimin Z |
| Genomic characteristics and prognosis of lung cancer patients with MSI-H: A cohort study. Lung cancer (Amsterdam, Netherlands) 2023 5 181 107255. Jie Tian, Hongdan Wang, Conghua Lu, Lan Liu, Xianquan Zhang, Yunbo Xie, Rutian Li, Xin Lv, Dan Fu, Ling Zhang, Xisheng Fang, Xuming Wang, Jing Hu, Xinyi Liu, Xiaochun Huang, Qian Zhao, Nuo Luo, Huan Tang, Zhaoyang Zhong, Yong He, Li |
| Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer. European journal of cancer (Oxford, England : 1990) 2023 5 188 81-89. Yiquan Xu, Jingjing Yan, Chengzhi Zhou, Lin Wu, Haibo Wang, Jun Zhao, Maolin Zhou, Jingyi Wang, Xinlong Zheng, Longfeng Zhang, Kan Jiang, Xiaobin Zheng, Qian Miao, Shiwen Wu, Zihua Zou, Rong Lian, Yuange He, Rongrong Chen, Shanshan Yang, Yujing Li, Sihui Chen, Gen L |
| Efficacy and safety analysis of anlotinib combined with PD-1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study. Journal of thoracic disease 2023 5 15 (4): 2003-2011. Xuanting Ye, Aimi Huang, Yan Zhou, Yanbin Kuang, Weimin Wang, Aiqin Gu, Ling |
| The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients. Discovery medicine 2023 5 35 (175): 131-143. Zhu Liang, Guoxiong Zeng, Wang Wan, Biao Deng, Chunyuan Chen, Fasheng Li, Guanzhou Lin, Yuying Lin, Haitao Lin, Guixi Mo, Huilai Mi |
| Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor. Journal of cancer research and clinical oncology 2023 4 . Ying Lin, Bo Yu, Haifeng Sun, Hongyu Zhang, Zhihuang Hu, Yao Zhang, Zhenhua Wu, Si Sun, Xinmin Zhao, Hui Yu, Xianghua Wu, Yuan Li, Jialei Wang, Huijie Wa |
| Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Biagio Ricciuti, Arielle Elkrief, Joao Alessi, Xinan Wang, Yvonne Li, Hersh Gupta, Daniel M Muldoon, Arrien A Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana Barrichello, Victor R Vaz, Malini Gandhi, Elinton Lee, Geoffrey I Shapiro, Hyesun Park, Mizuki Nishino, James Lindsay, Kristen D Felt, Bijaya Sharma, Andrew D Cherniack, Scott Rodig, Daniel R Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A Janne, Adam J Schoenfeld, Lynette M Sholl, Mark M Awad, Michael L Che |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: